Company Overview
Snapshot
Founded in June 2022 by Tal Shapsa Heiman, Or Bar Tal, Dan Ariely, and Ron Sabar, Epilog operates with 11–50 employees. The company has raised $1.3M across two funding rounds. In October 2025, Epilog secured a Seed funding round from Adama Ventures.
Business overview
Epilog is a Health Tech & Life Sciences company focused on improving the quality of life and reducing economic burdens associated with end-of-life care, particularly for individuals facing life-threatening medical diagnoses. The company develops a platform designed with behavioral principles to help patients manage medical and life decisions in real-time, shifting the focus from disease management to life management. Epilog serves patients, healthcare providers, and insurance companies within the digital healthcare and patient engagement sectors, utilizing mobile platforms and artificial intelligence.
Log in to access full profile ›Company Intelligence Q&A
- When was Epilog founded?
- Epilog was founded in June 2022 by Tal Shapsa Heiman, Or Bar Tal, Dan Ariely, and Ron Sabar.
- How much capital has Epilog raised to date?
- Epilog has raised a total of $1.3M across two funding rounds.
- What is Epilog's primary focus?
- Epilog focuses on redefining care in the last chapter of life by improving quality of life and reducing the economic burden of decision-making for individuals with life-threatening medical diagnoses.
- What technology does Epilog utilize in its platform?
- Epilog's platform leverages mobile technology and artificial intelligence, designed with behavioral principles, to assist users in managing medical and life decisions.